Related Experiment Video
Updated: Jul 10, 2026
07:00
A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
Genetic polymorphisms within the human Toll-like receptor 2 subfamily
R I Tapping1, K O Omueti, C M Johnson
1Department of Microbiology and College of Medicine, University of Illinois at Urbana/Champaign, Urbana, IL 61821, USA. tapping@life.uiuc.edu
Biochemical Society Transactions
|November 23, 2007
Summary
Toll-like receptors (TLRs) are key innate immune sensors for pathogens. This review examines vertebrate TLR evolution and function, focusing on TLR1, 2, 6, and 10, and their link to infectious disease via genetic variations.
Area of Science:
- Immunology
- Evolutionary Biology
- Genetics
Background:
- Infectious diseases exert significant evolutionary pressure on species.
- Toll-like receptors (TLRs) are crucial pattern-recognition molecules in the innate immune system.
- TLRs detect a wide range of pathogens, initiating host defense responses.
Purpose of the Study:
- To review the function and evolution of vertebrate Toll-like receptors (TLRs).
- To focus on the TLR1, 2, 6, and 10 subfamily in vertebrates.
- To explore the role of genetic variations (single nucleotide polymorphisms) in TLRs concerning infectious disease susceptibility.
Main Methods:
- Literature review of vertebrate TLR function and evolution.
- Analysis of evolutionary selection pressures on TLRs.
- Discussion of single nucleotide polymorphisms within TLR genes.
Main Results:
- Vertebrate TLRs exhibit complex evolutionary trajectories.
- The TLR1, 2, 6, and 10 subfamily plays a significant role in host-pathogen interactions.
- Evidence suggests TLRs are under strong purifying selection.
- Single nucleotide polymorphisms in TLRs are frequently associated with infectious disease incidence.
Conclusions:
- TLRs are vital for innate immunity and host defense against diverse pathogens.
- Evolutionary studies of TLRs, particularly the TLR1/2/6/10 subfamily, offer insights into immune system adaptation.
- Genetic variations in TLRs contribute to differential susceptibility to infectious diseases.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:28Diversity of Antigen Receptors
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:22T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...